Valor20202021202220232024TTMGastos comerciales, generales y administrativos731.32 M1.5 B1.3 B1.25 B1.33 B1.39 BInvestigación y desarrollo66.33 M87.94 M101.58 M103.68 M107.65 M111.75 MBeneficio operativo548.37 M425.62 M268.19 M836.12 M866.64 M1 BTotal de ingresos no operativos-30.84 M-111.11 M-110.84 M-133.31 M-70.43 M-60.93 MGastos por intereses, netos de intereses capitalizados37.18 M89.59 M107.99 M144.35 M86.26 M62.76 MIngresos no operativos, una vez deducidos los gastos por intereses-74.36 M-206.99 M-215.98 M-288.7 M-165.1 M-134.4 MIngresos/gastos extraordinarios6.34 M6.28 M-2.85 M11.04 M8.4 M10.7 MBeneficio antes de impuestos517.53 M314.5 M157.35 M702.81 M796.21 M940.21 MParticipación en los beneficios——————Impuestos120.66 M71.63 M51.53 M149.53 M184.65 M228.45 MParticipación minoritaria-530 K-1.02 M-1.22 M1.84 M1.43 M3.13 MOtros ingresos/gastos después de impuestos-24.27 M21.64 M24.83 M-12.32 M3.75 M-15.65 MBeneficio neto antes de actividades interrumpidas397.4 M243.89 M107.03 M551.44 M610.12 M708.72 MOperaciones suspendidas———-173.2 M4.52 M-783 KBeneficio neto397.4 M243.89 M107.03 M378.24 M614.64 M707.94 MAjuste por dilución——————Dividendos de las acciones preferentes——————Beneficio neto diluido atribuible a los accionistas397.4 M243.89 M107.03 M378.24 M614.64 M707.94 MBeneficio básico por acción4.662.51.073.836.247.2Beneficio por acción diluido4.632.481.073.816.27.17Número medio de acciones ordinarias85.2 M97.53 M99.71 M98.79 M98.58 M393.57 MAcciones diluidas85.9 M98.33 M100.25 M99.36 M99.07 M395.27 MEBITDA767.61 M978.72 M821.08 M1.4 B1.34 B2.33 BEBIT548.37 M425.62 M268.19 M836.12 M866.64 M1.84 BCosto de los ingresos1.76 B2.57 B2.8 B2.92 B3.06 B—Otros costes de producción——————Amortización y depreciación (flujo de caja)219.24 M553.1 M552.9 M565.24 M476.21 M485.42 M
STERIS plc (Ireland)
Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018.
Steris is listed on the New York Stock Exchange, and is a constituent of the S&P 500 Index. As of 2024, the President and CEO is Daniel A. Carestio.